PACT-Mexico-header

PACT multidisciplinary care workshop held in Mexico

The WFH Path to Access to Care and Treatment (PACT) Program is a 5-year initiative designed to improve outreach and diagnosis, and increase access to sustainable care for people with inherited bleeding disorders. This is achieved through training, education, partnerships, in-country initiatives, and evidence-based advocacy.

Also available in: Français Español

In Mexico, the WFH national member organization (NMO)—the Federación de Hemofilia de la República Mexicana (FHRM)—identified the creation of multidisciplinary care teams as a priority for the WFH PACT Program in the country. Since Mexico has a decentralized healthcare system, treatment standards vary across the 131 hemophilia treatment centres (HTCs) in the country. Thus, there is a strong need for consistent, nationwide training of healthcare practitioners (HCPs).

One of the strategies employed to increase capacity levels was to deliver HCP training at the National Hemophilia Congress, a biennial event that brings the bleeding disorders community together to learn and share experiences. Having specialized training for HCPs during the national congress made it possible to train more specialists on the standards of care for PWBDs.   

This year, the National Hemophilia Congress was held in August, and focused on musculoskeletal (MSK) care for PWBDs. This topic has been identified as a priority, as there are many PWBDs in Mexico who suffer from joint damage, or who are at risk of having MSK complications due to suboptimal access to treatment. This is in line with findings published in the 2021 Annual Global Survey: only 27% of adults with severe hemophilia were reported as having access to prophylaxis globally.

Specialists worked together to develop a scientific program for the workshop. The topics covered included general care, physiotherapy, and training on how to best support PWBDs who have undergone—or who might require —corrective surgery or joint replacement.

Holding a conference for family members and patients in parallel with the Congress allowed us to recognize the most relevant and necessary topics for health professionals. This will allow them to provide adequate care to patients with hemophilia and other coagulopathies in all areas.

—Cecilia Gallardo, volunteer physiotherapist at the FHRM-run Casa de la Hemophilia physiotherapy clinic

Almost 200 medical professionals participated in the training, and plans were made to provide further training to other medical professionals from the same hospitals. Trainers also had the opportunity to perform joint assessments for 40 people out of the 382 PWBDs who attended the event. This assessment helped identify patients who are candidates for surgery, or who require physiotherapy or other simple interventions that are covered in regional hospitals. Unfortunately, in Mexico, there is no standardized guidelines for the management of bleeding disorders, so the FHRM has been advocating for harmonized standards of care across the country based on recommendations from the WFH Guidelines for the Management of Hemophilia, 3rd edition.

“This event has been a milestone in our mission to raise awareness about bleeding disorders and improve the quality of life of PWBDs,” explains Minerva Cruz, President of the Federación de Hemofilia de la República Mexicana. “During the congress, we had the opportunity to bring together patients, families, healthcare professionals and leaders in the field of hemophilia care. Together, we shared knowledge and experiences. This will make a difference in the care and treatment of PWBDs in Mexico.”

The MSK training held as part of the National Hemophilia Congress was supported through the WFH PACT Program. The WFH and the FHRM also used the planning process as an opportunity to strategize on ways to expand medical care in the future— with focus on improving access to multidisciplinary care in HTCs that are dependent on both the public and social security healthcare systems.

To find out more about the WFH Path to Access to Care and Treatment (PACT) Program, please click here.

The PACT Program is supported by funding from Roche and Sanofi, our visionary partners; CSL Behring and Pfizer, our leadership partners; and Bayer, Biotest and Grifols, our collaborating partners.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.